The National Organization for Rare Disorders announced that CNBC "Squawk Box" co-anchor Becky Quick will moderate a CEO leadership dialogue on the next decade of rare disease treatment at the NORD Breakthrough Summit.
CEOs from BioMarin, Jazz Pharmaceuticals and Otsuka will join the NORD CEO to examine what it takes to turn scientific advancements into patient progress.
The panel will be held in Washington.
